Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ganglioside GM1 elevation in DBA/2 mouse embryos.

J D Bouvier¹, T N Seyfried

¹Department of Biology, Boston College, Chestnut Hill, Mass.

Developmental Neuroscience

|January 1, 1990

Summary

DBA/2 mouse embryos show lower ganglioside sialic acid levels and altered ganglioside profiles, specifically elevated GM1. This suggests reduced GM1 beta-galactosidase activity may be present during embryonic development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson's Disease.

ASN neuro·2018

Same author

Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.

PloS one·2015

Same author

Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.

Gene therapy·2014

Same author

Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer.

International journal of cancer·2014

Same author

Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.

Neurochemical research·2012

Same author

Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery.

Molecular therapy : the journal of the American Society of Gene Therapy·2006

Area of Science:

Developmental Biology
Neuroscience
Biochemistry

Background:

Gangliosides are crucial glycosphingolipids involved in cellular processes.
Mouse strain differences in ganglioside composition can impact development.
Previous studies indicated altered ganglioside metabolism in postnatal DBA mice.

Purpose of the Study:

To compare whole embryo ganglioside composition across three mouse strains (C57BL/6, DBA/2, C3H) at embryonic day 12.
To investigate potential alterations in ganglioside metabolism during early embryonic development in DBA/2 mice.

Main Methods:

Analysis of whole embryo ganglioside composition.
Quantification of sialic acid species and major ganglioside species (GM3, GD3, GD1a, GQ1b, GM1).
Comparative analysis across C57BL/6, DBA/2, and C3H mouse strains.

Main Results:

N-acetylneuraminic acid was the predominant sialic acid; N-glycolyneuraminic acid was minimal.
DBA/2 embryos exhibited significantly lower whole embryo ganglioside sialic acid concentration.
DBA/2 embryos showed an elevation in GD1a and GM1, with a reduction in GQ1b compared to C57BL/6 and C3H embryos.

Conclusions:

Embryonic day 12 DBA/2 mouse embryos display distinct ganglioside profiles.
The observed elevation of GM1 in DBA/2 embryos may stem from reduced GM1 beta-galactosidase activity.
These findings suggest potential early-onset metabolic differences in ganglioside processing in DBA/2 mice.

Related Experiment Videos